Pyxis Oncology Inc. (NASDAQ: PYXS)
$3.56
+0.3600 ( +11.25% ) 851.3K
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Market Data
Open
$3.56
Previous close
$3.20
Volume
851.3K
Market cap
$209.64M
Day range
$3.18 - $3.63
52 week range
$1.35 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 22, 2023 |
4 | Insider transactions | 1 | Sep 22, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 13, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
4 | Insider transactions | 1 | Aug 25, 2023 |
3 | Insider transactions | 2 | Aug 25, 2023 |
8-k | 8K-related | 14 | Aug 23, 2023 |